Literature DB >> 11769265

Treatment of knee contracture in cerebral palsy by hamstring lengthening, posterior capsulotomy, and quadriceps mechanism shortening.

R K Beals1.   

Abstract

Results of surgery to correct fixed flexion contracture of the knee and improve voluntary knee extension in 39 knees in 20 children (11 females, 9 males; mean age 12 years 8 months, age range 5 to 20 years) with cerebral palsy were analyzed. All patients had neuromotor disease and 18 children had spastic diplegia or quadriplegia. All patients could initiate voluntary knee extension but lacked full passive extension. Five patients (10 knees) were free walkers with a mean motor severity index of 19 and mean fixed knee contracture of 20 degrees. Fifteen patients (29 knees) were not free walkers and 13 were wheelchair ambulators. They had a mean motor severity index of 8 and mean fixed knee contractures of 30 degrees. Surgical procedures included various combinations of hamstring lengthening and/or posterior capsulotomy to allow free passive knee extension, with or without quadriceps mechanism shortening, to enhance voluntary extension. The best results were in patients who had hamstring lengthening, posterior capsulotomy, and quadriceps mechanism shortening.

Entities:  

Mesh:

Year:  2001        PMID: 11769265     DOI: 10.1017/s0012162201001451

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  14 in total

1.  [Muscle physiology and the effect of muscle-tendon surgery in cerebral palsy].

Authors:  R Brunner
Journal:  Orthopade       Date:  2004-10       Impact factor: 1.087

2.  Hamstring contractures in children with spastic cerebral palsy result from a stiffer extracellular matrix and increased in vivo sarcomere length.

Authors:  Lucas R Smith; Ki S Lee; Samuel R Ward; Henry G Chambers; Richard L Lieber
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

3.  Variation of hamstrings lengths and velocities with walking speed.

Authors:  Kiran J Agarwal-Harding; Michael H Schwartz; Scott L Delp
Journal:  J Biomech       Date:  2010-04-08       Impact factor: 2.712

4.  Anterior distal femoral hemiepiphysiodesis in the treatment of fixed knee flexion contracture in neuromuscular patients.

Authors:  Zaid Al-Aubaidi; Bjarne Lundgaard; Niels Wisbech Pedersen
Journal:  J Child Orthop       Date:  2012-07-14       Impact factor: 1.548

5.  Recurrence of knee flexion contracture after surgical correction in children with cerebral palsy.

Authors:  Supitchakarn Cheewasukanon; Phatcharapa Osateerakun; Noppachart Limpaphayom
Journal:  Int Orthop       Date:  2021-04-06       Impact factor: 3.075

6.  Influence of patellar position on the knee extensor mechanism in normal and crouched walking.

Authors:  Rachel L Lenhart; Scott C E Brandon; Colin R Smith; Tom F Novacheck; Michael H Schwartz; Darryl G Thelen
Journal:  J Biomech       Date:  2016-11-22       Impact factor: 2.712

7.  A functional electrical stimulation system improves knee control in crouch gait.

Authors:  Sam Khamis; Raz Martikaro; Shlomo Wientroub; Yoram Hemo; Shlomo Hayek
Journal:  J Child Orthop       Date:  2015-03-19       Impact factor: 1.548

8.  Operative treatment of the knee contractures in cerebral palsy patients.

Authors:  Zoran Bozinovski; Neron Popovski
Journal:  Med Arch       Date:  2014-05-31

9.  Knee Moment-Angle Characteristics and Semitendinosus Muscle Morphology in Children with Spastic Paresis Selected for Medial Hamstring Lengthening.

Authors:  Helga Haberfehlner; Richard T Jaspers; Erich Rutz; Jules G Becher; Jaap Harlaar; Johannes A van der Sluijs; Melinda M Witbreuk; Jacqueline Romkes; Marie Freslier; Reinald Brunner; Huub Maas; Annemieke I Buizer
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

10.  Single-stage multilevel soft-tissue surgery in the lower limbs with spastic cerebral palsy: Experience from a rehabilitation unit.

Authors:  Anupam Gupta; Abhishek Srivastava; Arun B Taly; Thyloth Murali
Journal:  Indian J Orthop       Date:  2008-10       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.